Croda stock slips as FTSE 100 weakness meets sector pressure

Croda stock moves lower on August 18, 2026 as the FTSE 100 weakens and the shares trade at 3,113.00p after a 1.33% drop.

Croda International plc (GB00BJFFLV09) shares fell to 3,113.00p on August 18, 2026, a 1.33% drop in the latest Tradegate-linked snapshot. The move came alongside a softer FTSE 100 and a broader risk-off tone in London trading.

Market tone turns softer

MarketScreener showed Croda at 36.44 EUR with a 2.36% decline in its August 18, 2026 Tradegate feed, while Sharecast put the London line at 3,113.00p, down 1.33% on the session. The gap between the two quotes reflects venue and currency differences, but both point to the same direction.

The broader UK backdrop was weak enough to matter for defensives and cyclicals alike. One market snapshot showed the FTSE 100 losing 0.3% to 10,720.30 on August 18, 2026, which gives Croda's move a clear index context.

What the latest numbers say

Croda's latest reported half-year figures showed sales of GBP 884.0 million and adjusted pre-tax profit of GBP 163.0 million, with the company also pointing to a 10.0% return on sales for the period. Those results were the most recent reported fundamentals visible in the material used for this note and provide the operating baseline for investors.

The comparison that stands out is historical: in fiscal 2023, Croda reported revenue of GBP 1.76 billion and adjusted pre-tax profit of GBP 273.0 million, which is materially larger than the half-year base because the periods are not directly comparable. For a cleaner read, the latest half-year sales still show how much of the business depends on pricing, mix, and end-market demand.

Portfolio mix matters

Croda's life sciences, consumer care, and industrial specialties portfolio means the shares often react to margin signals as much as to headline growth. That makes a sales figure of GBP 884.0 million and a 10.0% return on sales more useful than a simple price move alone.

Investor focus also stays on the group's chemical ingredients exposure, where product mix and customer demand can shift quickly between quarters. The latest half-year figures suggest the market is still pricing the business on execution rather than on a single catalyst.

Smart science ingredients

Croda's ingredients span beauty, health, and industrial applications, so one product line rarely defines the whole investment case. That broad mix is why the latest half-year margin and sales figures matter more than any single launch.

Croda stock finished the latest cited session at 3,113.00p, with the MarketScreener Tradegate snapshot at 36.44 EUR and a 2.36% decline on August 18, 2026. As of August 18, 2026, the shares are trading against a softer index backdrop rather than against a company-specific shock.

Fact box

Company: Croda International plc

ISIN: GB00BJFFLV09

Ticker: CRDA

Exchange: London Stock Exchange

Price (as of August 18, 2026, 3:19 p.m. ET): 3,113.00p

Market cap: GBP 4.3 billion

Sector / Industry: Materials / Specialty Chemicals

Index membership: FTSE 100

Read more

More on Croda stock and its latest market context